Compounding pharmacies have been allowed to essentially make a cheaper version of Eli Lilly's Zepbound, but they have to stop ...

As AstraZeneca awaits an FDA decision for its Daiichi Sankyo-partnered Datroway in EGFR-mutated non-small cell lung cancer ...

Q4 2024 Management View CEO Linda Marban highlighted the acceptance by the FDA of Capricor's Biologics License Application (BLA) for deramiocel, targeting treatment of Duchenne muscular dystrophy (DMD ...

President Biden exceeded expectations for the depths he was willing to go with a decision to advance a Food and Drug ...

On the heels of a Consumer Reports investigation into heavy metals turning up in baby formula, the Department of Health and ...

Over 197,000 cans of Target's Good & Gather Cut Green Beans were recalled last month due to potential foreign object ...

The FDA and HHS announced "Operation Stork Speed" Tuesday, which aims to increase testing for heavy metals and other ...

Nearly 200,000 cans of green beans have been recalled by the U.S. Food and Drug Administration due to potential contamination ...

After bringing Zolgensma to market in 2019 as the first gene therapy for spinal muscular atrophy, Novartis is back with a ...

Nestlé USA recalled four products due to possible presence of "wood-like material." It's one of the recent recalls that could ...

When combined with trastuzumab and chemotherapy, treatment with pembrolizumab was associated with a statistically significant improvement in PFS and OS compared with placebo.

The Food and Drug Administration has identified a Class I recall of Medtronic Neurovascular 027 Compatible Pipeline Vantage ...